Thomas J. Schuetz is CEO at Compass Therapeutics, Inc. (CMPX). They have made 24 open-market trades across 3 companies since 2015, most recently 2026-02-08.
CIK 0001591464
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
24 open-market purchases totalling $2.3M since 2016, never a sale. Across 23 scored buys the stock is up 29.3% at ninety days, and 27.2 points ahead of the S&P over the same stretch.
23 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 48% | 57% | 65% |
| Avg Move | +7.1% | +8.2% | +29.3% |
| Alpha | +7.6% | +9.8% | +27.2% |
| Scored | 23 | 23 | 23 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CMPX | BUY | 2025-05-27 | 2025-05-27 | $2.11 | $21K | +18.5% | +23.2% | +43.1% |
| CMPX | BUY | 2023-03-10 | 2023-03-10 | $3.37 | $34K | -3.7% | +5.5% | -7.1% |
| CMPX | BUY | 2023-02-27 | 2023-02-27 | $3.98 | $80K | -8.9% | -18.4% | -28.3% |
| CMPX | BUY | 2023-02-15 | 2023-02-15 | $3.86 | $77K | -4.1% | -13.9% | -17.2% |
| CMPX | BUY | 2023-01-31 | 2023-01-31 | $4.05 | $81K | -4.0% | -8.5% | -21.6% |
| CMPX | BUY | 2023-01-24 | 2023-01-24 | $4.19 | $168K | -4.6% | -4.8% | -29.7% |
| CMPX | BUY | 2022-09-28 | 2022-09-28 | $2.32 | $23K | +18.3% | +32.5% | +121.7% |
| CMPX | BUY | 2022-09-26 | 2022-09-27 | $2.27 | $34K | +35.4% | +47.8% | +154.5% |
| CMPX | BUY | 2022-09-07 | 2022-09-08 | $3.03 | $45K | -4.9% | -6.9% | +47.5% |
| CMPX | BUY | 2022-09-01 | 2022-09-01 | $2.83 | $42K | +17.4% | -11.1% | +43.2% |
| CMPX | BUY | 2022-08-17 | 2022-08-17 | $3.05 | $46K | +0.0% | +3.7% | +61.6% |
| CMPX | BUY | 2022-08-10 | 2022-08-10 | $2.64 | $40K | +15.1% | +12.8% | +60.4% |
| CMPX | BUY | 2022-08-01 | 2022-08-02 | $2.58 | $39K | +13.2% | +9.4% | +19.2% |
| CMPX | BUY | 2022-06-21 | 2022-06-21 | $2.80 | $56K | -11.4% | -8.0% | +0.0% |
| CMPX | BUY | 2022-06-16 | 2022-06-17 | $2.34 | $47K | +3.9% | +6.7% | +22.4% |
| CMPX | BUY | 2022-06-13 | 2022-06-13 | $2.29 | $69K | +45.8% | +42.7% | +55.2% |
| CMPX | BUY | 2022-06-06 | 2022-06-07 | $2.83 | $85K | -8.1% | +5.5% | +14.8% |
| CMPX | BUY | 2022-06-01 | 2022-06-01 | $3.03 | $121K | -33.0% | -11.7% | -0.3% |
| CMPX | BUY | 2022-05-26 | 2022-05-26 | $3.04 | $61K | -9.2% | -10.2% | +0.0% |
| CMPX | BUY | 2022-05-23 | 2022-05-24 | $2.72 | $50K | -0.7% | -3.2% | +9.3% |
| CMPX | BUY | 2022-05-17 | 2022-05-17 | $2.47 | $50K | +30.2% | +6.5% | +25.0% |
| CMPX | BUY | 2022-05-10 | 2022-05-10 | $1.80 | $100K | +48.0% | +44.0% | +48.6% |
| PrivateCompass Therapeutics, Inc. | BUY | 2020-06-19 | 2020-06-23 | $5.00 | $487K | N/A | N/A | N/A |
| RLYP | BUY | 2016-03-15 | 2016-03-16 | $13.39 | $402K | +9.1% | +45.7% | +51.6% |
| RLYP | SELL · 10b5-1 | 2015-06-11 | 2015-06-15 | $34.57 | $35K | -30.6% | +0.6% | +0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.